Optimizing treatment of hepatic metastases from colorectal cancer: resection or resection plus ablation?
- A. Chiappa
- E. Bertani
- A.P. Zbar
- D. Foschi
- N. Fazio
- M. Zampino
- C. Belluco
- F. Orsi
- P.D. Vigna
- G. Bonomo
- M. Venturino
- C. Ferrari
- R. Biffi
DOIAbstract
The present study determines the oncologic outcome of the combined resection and ablation strategy for colorectal liver metastases (CRLM). Between January 1994 and December 2014, 360 patients underwent surgery for CRLM. There were 280 patients who underwent hepatic resection only (group 1) and 80 hepatic resection plus ablation (group 2). group 2 patients had a higher incidence of multiple metastases than group 1 cases (100% in group 2 vs. 28.2% in group 1; P<0.001) and bilobar involvement (76.5% in group 2 vs. 12.9% in group 1; P<0.001). Perioperative mortality was nil in either group with a higher postoperative complication rate amongst group 1 vs. group 2 cases (18 vs. 0, respectively). The median follow-up was 90 months (range, 1-180) w...
Add to ORKG